Frequency Rhythmic Electrical Modulated System (FREMS) and its effect on the treatment of painful diabetic peripheral neuropathy: A systematic review and meta-analysis.

Authors

  • Khaled Moghib Cairo university
  • Ayman Hassan
  • Yumna mahmoud

Keywords:

Frequency Rhythmic Electrical Modulated System., Diabetes Mellitus,, Diabetic peripheral neuropathy,

Abstract

BACKGROUND: Frequency Rhythmic Electrical Modulated System (FREMS) is an innovative method of transcutaneous non-invasive treatment for neuropathic pain in diabetes mellitus. This study aims to synthesize evidence from published clinical trials on the efficacy and safety of FREMS administration in patients with painful peripheral diabetic neuropathy compared to placebo (sham FREMS) or standard of care.

METHODS: This systematic review and meta-analysis were conducted following the PRISMA statement guidelines, we searched PubMed, Cochrane Central, Scopus, and Web of Science databases throughout February 2023. Then, we screened the articles for eligibility, extracted the relevant data, and assessed the risk of bias using the Cochrane Collaboration tool. The primary outcome measured was the effect of Frequency Rhythmic Electrical Modulated System (FREMS)on pain perception assessed by Visual analogue scale [VAS] or other pain scores, extracted data from relevant RCTs were analyzed using RevMan software version 5.4.1 for Windows. All steps of this study were prespecified, and the protocol was registered on PROSPERO (CRD42023400884).

RESULTS: Four RCTs with 210 patients were eligible for the final analysis. For the primary outcome included in the meta-analysis, the mean difference (MD) of change in the (VAS) from baseline to endpoint favoured FREMS over sham-FREMS (comparison with day-time: SMD = -0.45, 95% CI [-0.77 to -0.14], P=0.005; comparison with night-time SMD = -0.41, 95% CI [-0.78 to -0.04], P= 0.03 using a random effect model for both. The efficacy of FREMS decreased gradually, and its statistical significance was lost after the follow-up period (comparison with day-time SMD=0.11, 95% CI [-0.34 to 0.55], P=0.64 using a random effect model; comparison with night-time SMD =-0.13, 95% CI [-0.43 to 0.17], P=0.41 using a fixed effect model. For the secondary outcomes in the systematic review, studies showed no statistically significant difference in Quality of life questionnaires and sensory nerve conduction velocity. Studies on motor nerve conduction velocity, tactile, vibration, and thermal sensation showed conflicting results. All studies reported no major adverse events.

CONCLUSION: FREMS may offer a drug-free and non-invasive alternative or adjunct modality in pain of peripheral diabetic neuropathy management in patients who do not respond well to treatment or those who cannot tolerate side effects of the usual medications because few side effects were reported after FREMS usage, which in turn makes it safe and well tolerated. In addition to its pivotal role in pain reduction, FREMS may also help in improving sensory functions and NCV in DPN patients. So FREMS should be considered and incorporated into clinical guidelines if further studies continue to support its efficacy and safety

Metrics

Metrics Loading ...

References

Bibliography

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053.doi:10.2337/diacare.27.5.1047

Pop-Busui R, Ang L, Boulton AJM, et al. Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy. Arlington (VA): American Diabetes Association; February 2022.doi:10.2337/db2022-01

Shillo P, Sloan G, Greig M, et al. Painful and Painless Diabetic Neuropathies: What Is the Difference?. Curr Diab Rep. 2019;19(6):32. Published 2019 May 7. doi:10.1007/s11892-019-1150-5

Ziegler D, Tesfaye S, Spallone V, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract. 2022;186:109063. doi:10.1016/j.diabres.2021.109063

Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9(6):660-674. doi:10.1111/j.1526-4637.2007.00347.x

Barrella M, Toscano R, Goldoni M, Bevilacqua M. Frequency rhythmic electrical modulation system (FREMS) on H-reflex amplitudes in healthy subjects. Eura Medicophys. 2007;43(1):37-47.

Bosi E, Conti M, Vermigli C, et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005;48(5):817-823. doi:10.1007/s00125-005-1734-2

Bosi E, Bax G, Scionti L, et al. Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial. Diabetologia. 2013;56(3):467-475. doi:10.1007/s00125-012-2795-7

Gorczyca-Siudak D, Dziemidok P. The 8-Week Efficacy of Frequency Rhythmic Electrical Modulated System (FREMS) as an Add-on Therapy in the Treatment of Symptomatic Diabetic Peripheral Polyneuropathy. Int J Environ Res Public Health. 2022;20(1). doi:10.3390/ijerph20010111

Crasto W, Altaf Q-A, Selvaraj DR, et al. Frequency Rhythmic Electrical Modulation System (FREMS) to alleviate painful diabetic peripheral neuropathy: A pilot, randomised controlled trial (The FREMSTOP study). Diabet Med. 2022;39(3):e14710. doi:10.1111/dme.14710

Neuropathic Pain in Adults: Pharmacological Management in Non-Specialist Settings. NICE (UK); 2013..

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook doi:10.1002/9781119536604

Waterfield J, Sim J. Clinical assessment of pain by the visual analogue scale.Br. j. ther. rehabil. 1996;3(2):94-97. doi:10.12968/bjtr.1996.3.2.14869

Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Arch Chest Dis. 2015;78(3). doi:10.4081/monaldi.2012.121

Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160-164. doi:10.1136/bmj.305.6846.160

Chatzikosma G, Pafili K, Demetriou M, Vadikolias K, Maltezos E, Papanas N. Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus. Arch Med Sci. 2016;12(2):390-393. doi:10.5114/aoms.2016.59265

Weinstein S. Fifty years of somatosensory research: from the Semmes-Weinstein monofilaments to the Weinstein Enhanced Sensory Test. J Hand Ther. 1993;6(1):11-22; https://doi.org/10.1016/S0894-1130(12)80176-1.

McGill M, Molyneaux L, Yue DK. Use of the Semmes–Weinstein 5.07/10 gram monofilament: the long and the short of it. Diabet Med. 1998;19(7); doi.org/10.1002/(SICI)1096-9136(199807)15:7<615::AID-DIA641>3.0.CO;2-P.

Pitei DL, Watkins PJ, Stevens MJ, Edmonds ME. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med. 1994;11(9):872-876. doi:10.1111/j.1464-5491.1994.tb00371.x

Lumpatki SB, Kavitha KV, Manohar MV, Unnikrishnan AG. Approach to painful diabetic peripheral neuropathy - Chron Diabetes Res Pract. 2022;07. doi: 10.4103/cdrp.cdrp_4_22

Shukla G, Bhatia M, Behari M. Quantitative thermal sensory testing -- value of testing for both cold and warm sensation detection in evaluation of small fiber neuropathy. Clin Neurol Neurosurg. 2005;107(6):486-490. doi:10.1016/j.clineuro.2004.12.016

Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002;31(1):140-149. doi:10.1093/ije/31.1.140

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. doi:10.1186/1471-2288-14-135

Altman DG, Bland JM. Standard deviations and standard errors. BMJ. 2005;331(7521):903. doi:10.1136/bmj.331.7521.903

Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. (LEA); 1988. doi:10.4324/9780203771587

Rosenthal R, Rubin DB. Meta-analytic procedures for combining studies with multiple effect sizes. Psychol Bull. 1986;99(3):400-406. doi:10.1037/0033-2909.99.3.400

Zakin E, Abrams R, Simpson DM. Diabetic Neuropathy. Semin Neurol. 2019;39(5):560-569. doi:10.1055/s-0039-1688978

Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi:10.1136/bmj.39489.470347.AD

Terrin N, Schmid CH, Lau J, Olkin I. Adjusting for publication bias in the presence of heterogeneity [published correction appears in Stat Med. 2005 Mar 15;24(5):825-6]. Stat Med. 2003;22(13):2113-2126. doi:10.1002/sim.1461

Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316(7129):469-471. doi: https://doi.org/10.1136/bmj.316.7129.469

Wang EJ, Berninger LE, Komargodski O, Smith TJ. Painful Diabetic Neuropathy - Spinal Cord Stimulation, Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, and Scrambler Therapy: A Narrative Review. Pain Physician. 2022;25(8):E1163-E1173.

Downloads

Published

2025-01-01

How to Cite

Moghib, K., Hassan, A., & mahmoud, Y. (2025). Frequency Rhythmic Electrical Modulated System (FREMS) and its effect on the treatment of painful diabetic peripheral neuropathy: A systematic review and meta-analysis. International Journal of Medical Students, 12, S337. Retrieved from https://ijms.pitt.edu/IJMS/article/view/2849

Issue

Vol 12. (2024): Supplement 1

Section

Abstracts of the WCMSR

License

Copyright (c) 2024 Khaled Moghib, Yumna mahmoud, Ayman Hassan

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org